| dc.creator | Guevara Villalobos, Martha Liliana | |
| dc.creator | Pinilla Fonseca, Vanessa Elena | |
| dc.creator | Polanco Rodríguez, Fabián Enrique | |
| dc.creator | Suárez Valencia, Diana Yessenia | |
| dc.date.accessioned | 2022-11-28T20:16:22Z | |
| dc.date.accessioned | 2023-06-05T15:11:32Z | |
| dc.date.available | 2022-11-28T20:16:22Z | |
| dc.date.available | 2023-06-05T15:11:32Z | |
| dc.date.created | 2022-11-28T20:16:22Z | |
| dc.date.issued | 2021 | |
| dc.identifier | Guevara Villalobos, M, Pinilla Fonseca, V, Polanco Rodríguez, F, Suárez Valencia, D., Características sociodemográficas y perfil de atención médica en pacientes Covid-19. Clínica Juan N. Corpas. [Internet]. Bogotá: Fundación Universitaria Juan N. Corpas; 2021. 69 hojas. Recuperado a partir de: https://repositorio.juanncorpas.edu.co/handle/001/139 | |
| dc.identifier | https://repositorio.juanncorpas.edu.co/handle/001/139 | |
| dc.identifier | Fundación Universitaria Juan N. Corpas | |
| dc.identifier | Fundación Universitaria Juan N. Corpas | |
| dc.identifier | Repositorio Institucional Fundación Universitaria Juan N. Corpas | |
| dc.identifier | Repositorio Institucional Fundación Universitaria Juan N. Corpas | |
| dc.identifier | https://repositorio.juanncorpas.edu.co/ | |
| dc.identifier | https://repositorio.juanncorpas.edu.co/ | |
| dc.identifier.uri | https://repositorioslatinoamericanos.uchile.cl/handle/2250/6645505 | |
| dc.description.abstract | Se analiza una cohorte intrahospitalaria con padecimiento de SARS-COV2, en condiciones de morbilidad moderada a severa, en una institución de III nivel de Complejidad. Se caracterizo el perfil sociodemográfico, de comorbilidad, de patrón clínico COVID-19 al ingreso y evolución, racionalidad y curso de intervenciones diagnósticas, terapéuticas y de los desenlaces vitales. | |
| dc.description.abstract | An in-hospital cohort suffering from SARS-COV2 is analyzed, in conditions of moderate to severe morbidity, in a complex level III institution. The sociodemographic, comorbidity, COVID-19 clinical pattern at admission and
evolution, rationality and course of diagnostic, therapeutic and vital outcomes interventions were characterized. | |
| dc.language | spa | |
| dc.publisher | Fundación Universitaria Juan N. Corpas | |
| dc.publisher | Escuela de Medicina | |
| dc.publisher | Bogotá | |
| dc.relation | RedCol | |
| dc.relation | 1.Zunyou Wu MP. https://jamanetwork.com. [Online].; 2020 [cited 2021 2 24]. Available from: https://jamanetwork.com/journals/jama/fullarticle/2762130.
2.Suliman Khan RS. Emergence of a Novel Coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2: Biology and Therapeutic Options. [Online].; 2020 [cited 2021 2 24]. Available from:https://jcm.asm.org/content/58/5/e00187-20.
3.COBCM Bd. Blog Oficial del Colegio Oficial de Biólogos de la Comunidad de Madrid. [Online].; 2020 [cited 2021 3 21]. Available from: https://cobcm.net/blogcobcm/2020/04/14/sars-cov-2-biologia-estructura/.
4.Gorbalenya AE,B. The species Severe acute respiratory syndrome-related coronavirus. [Online].; 2020 [cited 2021 3 15]. Available from: https://doi.org/10.1038/s41564-020-0695-z.
5.Francisco Javier Díaz-Castrillón AITM. Editorial Medica Colombiana. [Online].; 2020 [cited 2021 2 22]. Available from: https://docs.bvsalud.org/biblioref/2020/05/1096519/covid-19.pdf.
6.Marín JEO. Revista Alerta. [Online].; 2020 [cited 2021 3 12]. Available from: https://doi.org/10.5377/alerta.v3i2.9619.
7.Tolosa A. Genetica Medica News. [Online].; 2020 [cited 2021 3 21]. Available
from: https://genotipia.com/genetica_medica_news/coronavirus-estructura-infeccion-
celulas/.
8.Bette Korber WMF. Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus. [Online].; 2020 [cited 20213 21]. Available from: https://www.sciencedirect.com/science/article/pii/S0092867420308205.
9.Vunnam KPP&SR. Springer Nature - Transmission of SARS-CoV-2: an update of current literature. [Online].; 2020 [cited 2021 3 14]. Available from: https://doi.org/10.1007/s10096-020-03961-1.
10.N VD. Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1. [Online].; 2020 [cited 2021 3 14]. Available from: https://www.nejm.org/doi/full/10.1056/nejmc2004973.
11.Liu RRWyR. Reuters. [Online].; 2021 [cited 2021 4 11]. Available from: https://www.reuters.com/article/salud-coronavirus-anal-idESKCN2AW260.
12.Chen X. British Journal of Ophthalmology. [Online].; 2020. Available from: https://bjo.bmj.com/content/early/2020/08/25/bjophthalmol-2020-316263.
13.Le Chan YYLW. Transfusion Medicine Reviews. [Online].; 2020. Available from: https://www.sciencedirect.com/science/article/pii/S0887796320300146.
14.Melissa M. Arons RN,KM. Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility. [Online].; 2020 [cited 2021 3 14]. Available from: https://www.nejm.org/doi/full/10.1056/nejmoa2008457.
15.Muge Cevik MT. SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis. [Online].; 2021 [cited 2021 5 05]. Available from: https://www.sciencedirect.com/science/article/pii/S2666524720301725.
16.Qiu X. Defining the role of asymptomatic SARS-CoV-2 transmission – a living systematic review. [Online].; 2021 [cited 2021 4 14]. Available from: https://www.medrxiv.org/content/10.1101/2020.09.01.20135194v1.
17.Control ECfDPa. European Centre for Disease Prevention and Control. [Online].; 2020 [cited 2021 4 11]. Available from: https://www.ecdc.europa.eu/en/covid-19/surveillance/surveillance-definitions.
18.Muge Cevik JLM. Clinical Infectious Diseases. [Online].; 2020 [cited 2021 411]. Available from: https://academic.oup.com/cid/advance article/doi/10.1093/cid/ciaa1442/5910315.
19.Sin Fun Sia LMY. Nature. [Online].; 2020 [cited 2021 4 11]. Available from: https://www.nature.com/articles/s41586-020-2342-5.
20.Monteil V. ScienceDirect. [Online].; 2020 [cited 2021 3 21]. Available from: https://www.sciencedirect.com/science/article/pii/S0092867420303998.
21.Varga Z FA. The Lancet. [Online].; 2020 [cited 2021 3 21]. Available from: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30937-5/fulltext.
22.Mangalmurti N HC. Immunity. [Online].; 2020 [cited 2021 3 21]. Available from: https://doi.org/10.1016/j.immuni.2020.06.017.
23.Liu PP. Circulation. [Online].; 2020 [cited 2021 4 11]. Available from: https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.120.047549.
24.Takahashi T. Nature. [Online].; 2020 [cited 2021 4 11]. Available from: https://www.nature.com/articles/s41586-020-2700-3.
25.Lucas C. Nature. [Online].; 2020 [cited 2021 4 11]. Available from: https://www.nature.com/articles/s41586-020-2588-y.
26.National_Cancer_Institute. NCI National Cancer Institute. [Online].; 2021 [cited 2021 4 11]. Available from: https://www.cancer.gov/about-cancer/coronavirus/coronavirus-cancer-patient-i
nformation.
27.National_Kidney_Foundation. National Kidney Foundation. [Online].; 2020 [cited 2021 4 11]. Available from: https://www.kidney.org/coronavirus/kidney-disease-covid-19.
28.American_Lung_Association. American_Lung_Association. [Online].; 2021 [cited 2021 4 11]. Available from: https://www.lung.org/lung-health-diseases/lung-disease-lookup/covid-19/chronic-lung-diseases-and-covid.
29.Gajewski M. Forbes. [Online].; 2021 [cited 2021 4 11]. Available from: https://www.forbes.com/sites/mishagajewski/2021/02/09/people-with-dementia-are-twice-as-likely-to-get-covid-19-and-four-times-more-likely-to-die-from-it/.
30.Wang Q. Alzheimer's Association. [Online].; 2021 [cited 2021 4 11]. Available from: https://alz-journals.onlinelibrary.wiley.com/doi/10.1002/alz.12296.
31.American_Diabetes_Association. American_Diabetes_Association. [Online].;
2021 [cited 2021 4 11]. Available from: https://www.diabetes.org/coronavirus-covid-19/how-coronavirus-impacts-people-with-diabetes.
32.NDSS. National Down Syndrome Society. [Online].; 2021 [cited 2021 4 11]. Available from: https://www.ndss.org/ndss-covid-19-down-syndrome-resource/.
33.Triana JFF. https://www.elsevier.es. [Online].; 2020 [cited 2021 4 11]. Available from: https://www.elsevier.es/es-revista-revista-colombiana-cardiologia-203-articulo- covid-19-enfermedad-cardiovascular-S0120563320300760.
34.NIH. National Institute Health. [Online].; 2020 [cited 2021 4 11]. Available from: https://www.covid19treatmentguidelines.nih.gov/special-populations/hiv/.
35.NIH. National Institute of Allergy and Infectious Diseasses. [Online].; 2020 [cited 2021 4 11]. Available from: https://www.niaid.nih.gov/diseases-conditions/types-pidds.
36.CDC. Centers for Disease Control and Prevention. [Online].; 2021 [cited 20214 11]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/liver-disease.html.
37.Shetye B. Obesityaction. [Online].; 2021 [cited 2021 4 11]. Available from: https://www.obesityaction.org/community/covid-19-and-obesity-what-does-it-mean-for-you/.
38.CDC. Centers for Diseasse Control and Prevention. [Online].; 2021 [cited 20214 11]. Available from: https://www.cdc.gov/obesity/data/obesity-and-covid-19.html.
39.Lokken EM. American Journal of Obstetrics Gynecology. [Online].; 2021 [cited 2021 4 11]. Available from: https://www.ajog.org/article/S0002-9378(21)00098-3/fulltext.
40. Jimenez-Ruiz CA. Archivos de Bronconeumología. [Online].; 2020 [cited 20214 11]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7381922/.
41.Ortiz M. Acta Neurologica Colombiana. [Online].; 2020 [cited 2021 4 11]. Available from: https://doi.org/10.22379/24224022280.
42.OMS. Organización Mundial de la Salud. [Online].; 2020 [cited 2021 3 21]. Available from: https://www.who.int/es/news-room/feature-stories/detail/how-do-vaccines-work.
43.FH. https://www.huesped.org.ar. [Online].; 2020 [cited 2021 3 21]. Available from: https://www.huesped.org.ar/informacion/vacunas/que-son-y-como-funcionan/.
44.Salud OMdl. https://www.who.int/es. [Online].; 2021 [cited 2021 3 21]. Available from:https://www.who.int/es/news-room/feature-stories/detail/the-race-for-a-covid-19-vaccine-explained.
45.Bolan B. Banner Health. [Online].; 2020 [cited 2021 3 21]. Available from: https://www.bannerhealth.com/es/healthcareblog/teach-me/what-is-herd-immunity.
46.INS_Colombia. Ministerio de Salud y Protección Social. [Online].; 2020 [cited 2021 3 21. Available from: https://www.minsalud.gov.co/Paginas/Como-se-desarrolla-una-vacuna.aspx.
47.College_Philadelphia. The College of Physicians of Philadelphia. [Online].; 2018 [cited 2021 3 21]. Available from: https://www.historyofvaccines.org/index.php/es/contenido/articulos/desarrollo-pruebas-y-reglamentos-para-las-vacunas.
48.Financial_Times. Financial Times. [Online].; 2021 [cited 2021 3 21]. Available from: https://www.ft.com/content/ac5e5ef8-bccb-482b-9f8d-0dab5cac6f9a.
49.Plotkin SA,OWA,OPA. https://www.historyofvaccines.org. [Online].; 2018 [cited 2021 03 21]. Available from: https://www.historyofvaccines.org/es/contenido/articulos/diferentes-tipos-de-va
cunas.
50.Hoffmann. BSK&C. The Lancet - Infectious Disease. [Online].; 2020 [cited 2021 5 3. Available from: https://doi.org/10.1016/S1473-3099(20)30581-8.
51.Worldmeter. www.worldometers. [Online].; 2021 [cited 2021 5 3. Available from: https://www.worldometers.info/.
52.SaludBogota. SaluData. [Online].; 2020 [cited 2021 1 31]. Available from: https://saludata.saludcapital.gov.co/osb/index.php/datos-de-salud/enfermedad es-trasmisibles/covid19/.
53.Carthaus A. Coronavirus: El factor R y los cuatro parámetros de contagio. [Online].; 2020 [cited 2021 3 31]. Available from: https://p.dw.com/p/3bH4u.
54.Diaz JA. RTColombia. [Online].; 2020 [cited 2021 3 31]. Available from: http://www.rtcolombia.com.
55.Statista. Statista.com. [Online].; 2021 [cited 2021 3 30]. Available from: https://es.statista.com/.
56.MinSalud. Ministerio de Salud Colombia. [Online].; 2021 [cited 2021 3 31]. Available from: https://www.minsalud.gov.co/salud/publica/Vacunacion/Paginas/Vacunacion-covid-19.aspx. | |
| dc.rights | Atribución 4.0 Internacional (CC BY 4.0) | |
| dc.rights | https://creativecommons.org/licenses/by/4.0/ | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.rights | http://purl.org/coar/access_right/c_abf2 | |
| dc.rights | Todos los derechos reservados conforme a la ley. Se permite la reproducción citando fuente. El pensamiento que se expresa en esta obra, es exclusiva responsabilidad de los autores y no compromete la ideología de la Fundación Universitaria Juan N. Corpas. | |
| dc.source | https://repositorio.juanncorpas.edu.co | |
| dc.title | Características sociodemográficas y perfil de atención médica en pacientes Covid-19 Clínica Juan N. Corpas | |
| dc.type | Trabajo de grado - Especialización | |
